Volume | 1 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Sarepta Therapeutics Inc New | SRPT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
130.83 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
1 | 1 | - | 55.25 - 152.21 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
07:22:58 | 1 | $ 130.83 | USD |
Sarepta Therapeutics (SRPT) Options Flow Summary
Sarepta Therapeutics Inc New Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
12.28B | 93.86M | - | 1.24B | -535.98M | -5.71 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Sarepta Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SRPT Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 133.55 | 134.715 | 128.75 | 132.11 | 925,834 | -2.72 | -2.04% |
1 Month | 117.50 | 146.68 | 117.06 | 130.67 | 1,172,579 | 13.33 | 11.34% |
3 Months | 138.73 | 146.68 | 114.37 | 127.54 | 907,955 | -7.90 | -5.69% |
6 Months | 85.03 | 146.68 | 78.67 | 115.60 | 1,053,519 | 45.80 | 53.86% |
1 Year | 150.35 | 152.21 | 55.25 | 108.79 | 1,200,155 | -19.52 | -12.98% |
3 Years | 80.31 | 159.89 | 55.25 | 103.71 | 1,102,465 | 50.52 | 62.91% |
5 Years | 118.12 | 181.83 | 55.25 | 106.95 | 1,149,339 | 12.71 | 10.76% |
Sarepta Therapeutics Description
Sarepta Therapeutics is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of Sarepta's product candidates are at an early stage of development. |